| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1999;68:2285-2291
© 1999 The Society of Thoracic Surgeons
a Division of Cardiovascular Surgery, Heart Institute for Children, Hope Children’s Hospital, Oak Lawn, Illinois, USA
Address reprint requests to Dr Allen, Heart Institute for Children, Hope Children’s Hospital, 4440 W 95th St, Oak Lawn, IL 60453
e-mail: brad{at}thic.com
Presented at the Thirty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 25–27, 1999.
Background. We have shown that magnesium can offset the detrimental effects of normocalcemic cardioplegia in hypoxic neonatal hearts. It is not known, however, whether magnesium offers any additional benefit when used in conjunction with hypocalcemic cardioplegia.
Methods. Twenty neonatal piglets underwent 60 minutes of ventilator hypoxia (FiO2 8% to 10%) followed by 20 minutes of normothermic ischemia on cardiopulmonary bypass (hypoxic-ischemic stress). They then underwent 70 minutes of multidose blood cardioplegic arrest. Five (Group 1), received a hypocalcemic (Ca+2 0.2 to 0.4 mM/L) cardiologic solution without magnesium, whereas in 10, magnesium was added at either a low dose (5 to 6 mEq/L, Group 2) or high dose (10 to 12 mEq/L, Group 3). In the last 5 (Group 4), magnesium (10 to 12 mEq/L) was added to a normocalcemic cardioplegic solution. Function was assessed using pressure volume loops and expressed as percentage of control.
Results. Compared to hypocalcemia cardioplegic solution without magnesium (Group 1), both high- and low-dose magnesium enrichment (Groups 2 and 3) improved myocardial protection resulting in complete return of systolic (40% vs 101% vs 102%) (p < 0.001 vs Groups 2 and 3) and global myocardial function (39% vs 102% vs 101%) (p < 0.001 vs Groups 2 and 3), and reduced diastolic stiffness (267% vs 158% vs 154%) (p < 0.001 vs Groups 2 and 3). Conversely, even high-dose magnesium supplementation could not offset the detrimental effects of normocalcemic cardioplegia resulting in depressed systolic (End Systolic Elastance [EES] 41% ± 1%) (p < 0.001 vs Groups 2 and 3) and global myocardial function (40% ± 1%) (p < 0.001 vs Groups 2 and 3), and a marked rise in diastolic stiffness (258% ± 5%) (p < 0.001 vs Groups 2 and 3). Hypocalcemic magnesium cardioplegia has now been used successfully in 247 adult and pediatric patients.
Conclusions. Magnesium enrichment of hypocalcemic cardioplegic solutions improves myocardial protection resulting in complete functional preservation. However, magnesium cannot prevent the detrimental effects of normocalcemic cardioplegia when the heart is severely stressed. This study, therefore, strongly supports using both a hypocalcemic cardioplegic solution and magnesium supplementation as their benefits are additive.
This article has been cited by other articles:
|
|
 |
|
  P. Giordano, G. Scrascia, D. D'Agostino, F. Mastro, C. Rotunno, M. Conte, R. Rociola, and D. Paparella Myocardial damage following cardiac surgery: comparison between single-dose Celsior cardioplegic solution and cold blood multi-dose cardioplegia Perfusion, May 13, 2013; (2013) 0267659113486827v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Allen and G. D. Buckberg Studies of isolated global brain ischaemia: I. Overview of irreversible brain injury and evolution of a new concept - redefining the time of brain death Eur J Cardiothorac Surg, May 1, 2012; 41(5): 1132 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Buckberg Controlled reperfusion after ischemia may be the unifying recovery denominator J. Thorac. Cardiovasc. Surg., July 1, 2010; 140(1): 12 - 18. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Modi and M. S. Suleiman Invited Commentary Ann. Thorac. Surg., May 1, 2009; 87(5): 1523 - 1524. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schlensak Myocardial protection in congenital heart surgery MMCTS, January 1, 2005; 2005(1129): mmcts.2004.000729 - mmcts.2004.000729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruel, T. A. Khan, P. Voisine, C. Bianchi, and F. W. Sellke Vasomotor dysfunction after cardiac surgery Eur J Cardiothorac Surg, November 1, 2004; 26(5): 1002 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. An, A. K. S. Camara, Q. Chen, and D. F. Stowe Effect of low [CaCl2] and high [MgCl2] cardioplegia and moderate hypothermic ischemia on myoplasmic [Ca2+] and cardiac function in intact hearts Eur J Cardiothorac Surg, December 1, 2003; 24(6): 974 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Allen, J. S. Veluz, G. D. Buckberg, E. Aeberhard, and L. J. Ignarro Deep hypothermic circulatory arrest and global reperfusion injury: Avoidance by making a pump prime reperfusate--A new concept J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 625 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yang, Y.-C. Liu, W. Zou, A. P. C. Yim, and G.-W. He Protective effect of magnesium on the endothelial function mediated by endothelium-derived hyperpolarizing factor in coronary arteries during cardioplegic arrest in a porcine model J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 361 - 370. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
